Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Other 1Lymphoid 1

Conditions

Sexuality 1Sexual Dysfunction, Physiological 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Infertility 1Hodgkin Disease 1Congenital Abnormalities 1

Interventions

pegaspargase 1nelarabine 1fludarabine phosphate 1Whole-Body Irradiation 1Vitamin D 1Vincristine 1Therapeutics 1Rituximab 1Radiotherapy 1Psychology, Positive 1Passive Cutaneous Anaphylaxis 1Morphine 1Methotrexate 1Methods 1Methadone 1Mercaptopurine 1Melphalan 1Imatinib Mesylate 1Hydromorphone 1High-Energy Shock Waves 1Gelclair 1Furosemide 1Fibroblast Growth Factor 7 1Etoposide 1Drug Therapy 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Calcium Citrate 1Calcium Carbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × High-Energy Shock Waves × Other × Clear all
NCT00402935 2012-03-20

Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for Cancer

Case Comprehensive Cancer Center

Withdrawn
LymphoidOtherOther hematologic neoplasm

Congenital Abnormalities, Hodgkin Disease, Infertility, Leukemia, Lymphoma, Recurrence, Sexual Dysfunction, Physiological, Leukemia, Myeloid, Acute, Sexuality, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡